Hydrodissection Between Normal Saline and a Combination of Triamcinolone Acetonide, Normal Saline, and Lidocaine in CTS

• Status: Recruiting
• Trial end date: 2023-09-12
• Target enrollment: 0
• Participant gender: All

Summary

The goal of this randomized clinical trial is to compare the functional outcome of hydrodissection of the median nerve by normal saline only and a combination of triamcinolone acetonide, lidocaine, and normal saline.

The main question it aims to answer are:

• What is the outcome comparison of ultrasound-guided hydrodissection between normal saline only and combination of triamcinolone acetonide, normal saline, and lidocaine in mild to moderate carpal tunnel syndrome?

Participants diagnosed with mild or moderate CTS will be randomly assigned to two groups and be hydrodissected under ultrasound guidance.

Researchers will compare if normal saline gives similar or better functional outcomes than steroids.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Bangladesh College Of Physicians And Surgeons (BCPS)
• Treatments: Triamcinolone; Triamcinolone Acetonide; Triamcinolone diacetate; Triamcinolone hexacetonide

Criteria

Inclusion Criteria:

• Patients having pain and/or numbness, paresthesia in median nerve or glove distribution area with night symptoms for more than 4 weeks

• Patients age from 18 years of both sexes

• Electrodiagnostically (by NCS) confirmed and categorized as mild or moderate carpal tunnel syndrome

• Willing to participate

Exclusion Criteria:

• Patients having other diseases, like: Cervical radiculopathy, Other neuropathy

• History of taking systemic corticosteroids within 04-weeks prior study

• Pregnancy

• History of distal forearm or wrist fracture, trauma or deformity

• Previous CTS surgery or steroid injection in carpal tunnel

• Thenar atrophy